Governance must now evolve from policy to practice, measured not in frameworks adopted but in safety assured.

Turning frameworks into patient-centered care requires action. Hospitals and health systems should:

• Include patients and frontline clinicians in governance committees to ensure real-world concerns and lived experiences shape AI policies.
• Mandate continuous monitoring and bias audits to regularly assess model performance and identify unintended consequences early.
• Ensure transparency at the point of care by informing patients when AI influences decisions and providing ways to question recommendations.
• Invest in workforce upskilling so clinicians and staff understand AI’s capabilities and limitations and can identify when simpler solutions suffice.

to regularly assess model performance and identify unintended consequences

What Regulators Now Expect From Bias Audits

The list above says "mandate continuous monitoring and bias audits." Fair enough. But in 2026, that is no longer just good practice, it is close to becoming the law of the land. The FDA's January 2026 guidance on AI-enabled medical devices moved the agency to a total product lifecycle approach, requiring developers to plan for postmarket performance monitoring and to document training data, bias testing, and intended clinical use before a product ever reaches your floor FDA AI lifecycle update. The agency has been direct about why: "Although bias may be difficult to eliminate completely, FDA recommends that manufacturers, as a starting point, ensure that the validation data sufficiently represents the intended use (target) population of a medical device" FDA AI device bias guidance.

That puts real teeth behind the bullet point Dan wrote above. A governance committee that "mandates bias audits" without asking a vendor for subgroup performance data, error rates by race, age, and sex, and a documented plan for drift monitoring is checking a box, not running a program. HHS's Office for Civil Rights has made this concrete for anyone using AI in coverage or clinical decisions tied to Medicare or Medicaid populations: Section 1557 makes algorithmic discrimination review non-optional NIST AI RMF for healthcare compliance roadmap. If your system touches those populations, and most hospital systems do, this is not aspirational governance. It is a compliance obligation with your name on it.

The practical version: before you sign a vendor contract, ask for the model card, the demographic breakdown of the validation data, and a written commitment to real-world performance monitoring. If a vendor cannot produce that documentation, that alone is your answer.

Who Actually Sits on the Committee

"Include patients and frontline clinicians in governance committees" is the right instinct, but committees fail when membership is vague. The clearest guidance I have seen comes from a synthesis of the Joint Commission and Coalition for Health AI (CHAI) frameworks, which recommend a cross-functional roster: clinical, nursing, informatics, quality and safety, privacy, security, legal, ethics, health equity, operations, and, explicitly, patient representatives, not as an afterthought but with named decision authority Clinical AI policy committee template.

Nursing deserves a specific mention here because nurses are usually the ones absorbing the practical consequences of a bad algorithm at 3 a.m., and they are frequently left off these committees entirely. A recent analysis of AI governance in nursing lays out a workable escalation model: frontline staff flag anomalous AI output, clinical informatics triages it, and if patient harm is suspected the committee chair convenes a review within 48 hours, with post-incident reviews due within 30 days AI governance in nursing. That is what "include clinicians" looks like operationally: a defined trigger, a named owner, and a clock.

One more governance lesson worth stealing: risk-tiering. Not every AI tool needs the same scrutiny. A sepsis alert and a billing summarizer carry very different stakes, and a workable governance model sorts every tool into a risk tier that sets the depth of review, the monitoring cadence, and who has approval authority Healthcare AI governance risk compliance playbook. Committees that try to review everything with the same rigor either rubber-stamp high-risk tools or grind low-risk ones to a halt. Neither protects patients.

• Require named decision authority on the committee roster, not just representation
• Give nursing and frontline clinical staff a documented escalation path with a time-bound response, not an open invitation to "raise concerns"
• Risk-tier every AI tool before deciding how much scrutiny it gets
• Request vendor model cards and subgroup performance data before signing, not after an incident

Transparency Has a New Federal Floor

The third bullet point calls for transparency "at the point of care." That principle now has regulatory backing. ONC's HTI-1 Final Rule establishes the first federal transparency requirements for AI and predictive algorithms embedded in certified health IT, requiring EHR vendors to give clinical users a consistent, baseline set of information about how an algorithm was designed, developed, trained, and evaluated, so clinicians can assess it for fairness, appropriateness, validity, effectiveness, and safety, the FAVES criteria ONC HTI-1 Final Rule overview.

That is a floor, not a ceiling. It obligates your EHR vendor to hand you information. It does not obligate your hospital to hand that information to patients, or to build the workflow that lets a clinician actually question an AI-influenced recommendation in the moment. That gap between what vendors must disclose and what patients experience at the bedside is exactly where hospital-level governance has to pick up the thread.

Continue the Conversation

If this resonated, here is where to go next: Join the AI-in-Healthcare Workshop · Get the Books · Contact Dan